BR9902041A - Processo de preparação de halogenetos de fenoxifenilsulfonila. - Google Patents

Processo de preparação de halogenetos de fenoxifenilsulfonila.

Info

Publication number
BR9902041A
BR9902041A BR9902041-6A BR9902041A BR9902041A BR 9902041 A BR9902041 A BR 9902041A BR 9902041 A BR9902041 A BR 9902041A BR 9902041 A BR9902041 A BR 9902041A
Authority
BR
Brazil
Prior art keywords
preparation
phenoxyphenylsulfonyl
halides
phenoxyphenylsulfonyl halides
phenoxyphenylsulphonyl
Prior art date
Application number
BR9902041-6A
Other languages
English (en)
Inventor
Joel Michael Hawkins
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9902041A publication Critical patent/BR9902041A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C301/00—Esters of sulfurous acid
    • C07C301/02—Esters of sulfurous acid having sulfite groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/75—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton

Abstract

Patente de Invenção: <B>''PROCESSO DE PREPARAçãO DE HALOGENETOS DE FENOXIFENILSULFONILA''<D>. Um processo para a preparação da halogenitos de fenoxifenilsulfonila, que são intermediários úteis para a preparação de inibidores de metaloproteinase de matriz.
BR9902041-6A 1998-04-10 1999-04-12 Processo de preparação de halogenetos de fenoxifenilsulfonila. BR9902041A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8139398P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
BR9902041A true BR9902041A (pt) 2000-05-02

Family

ID=22163859

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9902041-6A BR9902041A (pt) 1998-04-10 1999-04-12 Processo de preparação de halogenetos de fenoxifenilsulfonila.

Country Status (42)

Country Link
US (2) US6118016A (pt)
EP (1) EP0949246B1 (pt)
JP (1) JP3694419B2 (pt)
KR (1) KR100329901B1 (pt)
CN (1) CN1238329A (pt)
AP (1) AP1155A (pt)
AR (1) AR016205A1 (pt)
AT (1) ATE233729T1 (pt)
AU (1) AU758297B2 (pt)
BG (1) BG103321A (pt)
BR (1) BR9902041A (pt)
CA (1) CA2268679C (pt)
CO (1) CO4810300A1 (pt)
DE (1) DE69905633T2 (pt)
DK (1) DK0949246T3 (pt)
DZ (1) DZ2755A1 (pt)
EA (1) EA001756B1 (pt)
ES (1) ES2192021T3 (pt)
GT (1) GT199900044A (pt)
HR (1) HRP990107B1 (pt)
HU (1) HU221635B1 (pt)
ID (1) ID23645A (pt)
IL (1) IL129330A (pt)
IN (1) IN191233B (pt)
IS (1) IS5020A (pt)
MA (1) MA24834A1 (pt)
NO (1) NO991679L (pt)
NZ (1) NZ335106A (pt)
OA (1) OA11032A (pt)
PA (1) PA8469801A1 (pt)
PE (1) PE20000416A1 (pt)
PL (1) PL332452A1 (pt)
SG (1) SG75169A1 (pt)
SI (1) SI0949246T1 (pt)
SK (1) SK44999A3 (pt)
TN (1) TNSN99051A1 (pt)
TR (1) TR199900757A2 (pt)
TW (1) TW539664B (pt)
UA (1) UA59373C2 (pt)
UY (1) UY25472A1 (pt)
YU (1) YU18299A (pt)
ZA (1) ZA992628B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
ES2425013T3 (es) * 2002-06-12 2013-10-10 Symphony Evolution, Inc. Inhibidores de ADAM-10 humana
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
JP5830534B2 (ja) 2010-07-09 2015-12-09 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ 化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE844004C (de) * 1944-08-06 1952-07-14 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Sulfonsaeureestern
US4032506A (en) * 1973-12-28 1977-06-28 General Electric Company Flame retardant polycarbonate composition
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5340489A (en) * 1992-06-05 1994-08-23 The Dow Chemical Company Aryl arenesulfonates and a method of lubrication using the aryl arenesulfonates
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US6153609A (en) * 1996-08-23 2000-11-28 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
TR199901849T2 (xx) * 1997-02-03 2000-02-21 Pfizer Products Inc. Arils�lfonilamino hidroksamik asit t�revleri.
WO1998050348A1 (en) * 1997-05-09 1998-11-12 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
ATE217863T1 (de) * 1997-08-08 2002-06-15 Pfizer Prod Inc Arylsulfonylaminohydroxamsäurederivate
ATE263147T1 (de) * 1997-08-08 2004-04-15 Pfizer Prod Inc Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
PA8469401A1 (es) * 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
AU758297B2 (en) 2003-03-20
TW539664B (en) 2003-07-01
AP9901509A0 (en) 1999-06-30
SI0949246T1 (en) 2003-06-30
US6118016A (en) 2000-09-12
GT199900044A (es) 2000-09-14
PE20000416A1 (es) 2000-05-24
EA199900282A2 (ru) 1999-10-28
EP0949246A1 (en) 1999-10-13
HU9901042D0 (en) 1999-06-28
NO991679L (no) 1999-10-11
JPH11322704A (ja) 1999-11-24
DE69905633D1 (de) 2003-04-10
IS5020A (is) 1999-10-11
NZ335106A (en) 2000-09-29
CN1238329A (zh) 1999-12-15
EA001756B1 (ru) 2001-08-27
CA2268679C (en) 2004-07-27
TR199900757A3 (tr) 1999-11-22
AR016205A1 (es) 2001-06-20
ID23645A (id) 2000-05-04
TR199900757A2 (xx) 1999-11-22
BG103321A (en) 2001-08-31
JP3694419B2 (ja) 2005-09-14
HRP990107A2 (en) 2000-02-29
HU221635B1 (hu) 2002-12-28
HUP9901042A2 (hu) 1999-12-28
ZA992628B (en) 2000-10-09
NO991679D0 (no) 1999-04-09
PA8469801A1 (es) 2000-09-29
EP0949246B1 (en) 2003-03-05
SG75169A1 (en) 2000-09-19
YU18299A (sh) 2002-11-15
IL129330A0 (en) 2000-02-17
KR100329901B1 (ko) 2002-03-22
AP1155A (en) 2003-06-30
UA59373C2 (uk) 2003-09-15
KR19990082980A (ko) 1999-11-25
MA24834A1 (fr) 1999-12-31
OA11032A (en) 2002-02-06
AU2369299A (en) 1999-10-21
PL332452A1 (en) 1999-10-11
DE69905633T2 (de) 2003-11-06
HRP990107B1 (en) 2003-10-31
ATE233729T1 (de) 2003-03-15
IL129330A (en) 2003-12-10
UY25472A1 (es) 1999-11-17
HUP9901042A3 (en) 2000-06-28
DZ2755A1 (fr) 2003-09-15
SK44999A3 (en) 2000-09-12
TNSN99051A1 (fr) 2005-11-10
ES2192021T3 (es) 2003-09-16
CO4810300A1 (es) 1999-06-30
CA2268679A1 (en) 1999-10-10
DK0949246T3 (da) 2003-04-07
US20010011143A1 (en) 2001-08-02
EA199900282A3 (ru) 2000-04-24
IN191233B (pt) 2003-10-11

Similar Documents

Publication Publication Date Title
NO20011350D0 (no) 4-Karboksyaminosubstituerte 1,2,3,4-tetrahydrokinoliner som CETP inhibitorer
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
DK0882024T3 (da) Forbindelser, som inhiberer retroviral protease
MA26937A1 (fr) Nouvelle composition pharmaceutique.
NO994877L (no) Kalsilytiske forbindelser
BR9903984B1 (pt) processo para a produção de uma composição aquosa que contém um peptìdeo farmaceuticamente efetivo.
HUP9903863A2 (hu) Metalloproteináz-inhibitorok
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
NO954768D0 (no) N-alkyltiopolyaminderivater som radiobeskyttende midler
BR9812837A (pt) Processo para fazer um composto, e, composto
IT1317716B1 (it) Processo per la preparazione di perfluoropoliossialchileni conterminali ossidrilici.
NO20013675L (no) 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer
PT1154986E (pt) Processo para a preparacao de iopamidol
BR9916507A (pt) Proteìnas
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
BR0007922A (pt) Compostos calcilìticos
DK1027348T3 (da) 2-(2&#39;-hydroxyphenyl)benzotriazoler anvendt som UV-stabilisatorer
BR0311267A (pt) Sìntese de pirazóis
BR9902041A (pt) Processo de preparação de halogenetos de fenoxifenilsulfonila.
NO20003828D0 (no) 2,3,4,5-Tetrahydro-1H-[1,4]-benzodiazepin-3-hydroksamsyrer som matriks-metalloproteinaseinhibitorer
BR9808011B1 (pt) processo para a purificação de caprolactama.
BR9913027B1 (pt) processos para a produção do composto 3,5-difluoroanilina e de um composto de 1-halo-3,5-difluorobenzeno.
BR0006843A (pt) Dispositivo de embreagem
BR9807785A (pt) Processo para a preparação do composto, e, composto
BR9908511A (pt) Processo para a preparação de um composto, e, composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009.